Amundi

Amundi Portfolio holdings

AUM $290B
1-Year Return 20.97%
 

Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.

This Quarter Return
-14.72%
1 Year Return
+20.97%
3 Year Return
+97.23%
5 Year Return
10 Year Return
AUM
$125B
AUM Growth
-$23.1B
Cap. Flow
-$13.2M
Cap. Flow %
-0.01%
Top 10 Hldgs %
17.71%
Holding
1,754
New
104
Increased
630
Reduced
657
Closed
91

Sector Composition

1 Technology 22.39%
2 Healthcare 15.51%
3 Financials 12.11%
4 Consumer Discretionary 11.09%
5 Industrials 8.28%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
STAA icon
1301
STAAR Surgical
STAA
$1.38B
$135K ﹤0.01%
1,848
AXSM icon
1302
Axsome Therapeutics
AXSM
$6.25B
$135K ﹤0.01%
+3,053
New +$135K
FOLD icon
1303
Amicus Therapeutics
FOLD
$2.46B
$135K ﹤0.01%
12,280
MRCY icon
1304
Mercury Systems
MRCY
$4.13B
$134K ﹤0.01%
2,133
AVID
1305
DELISTED
Avid Technology Inc
AVID
$134K ﹤0.01%
5,080
-405
-7% -$10.7K
GBT
1306
DELISTED
Global Blood Therapeutics, Inc.
GBT
$132K ﹤0.01%
3,802
-370
-9% -$12.8K
BBIO icon
1307
BridgeBio Pharma
BBIO
$10.2B
$131K ﹤0.01%
13,866
+8,453
+156% +$79.9K
RVMD icon
1308
Revolution Medicines
RVMD
$7.57B
$131K ﹤0.01%
+5,611
New +$131K
AXON icon
1309
Axon Enterprise
AXON
$57.2B
$130K ﹤0.01%
1,424
-1,634
-53% -$149K
KRO icon
1310
KRONOS Worldwide
KRO
$713M
$130K ﹤0.01%
8,000
NVAX icon
1311
Novavax
NVAX
$1.28B
$130K ﹤0.01%
2,524
-29,250
-92% -$1.51M
KRYS icon
1312
Krystal Biotech
KRYS
$4.35B
$126K ﹤0.01%
+1,762
New +$126K
XNCR icon
1313
Xencor
XNCR
$610M
$123K ﹤0.01%
3,995
RPD icon
1314
Rapid7
RPD
$1.32B
$121K ﹤0.01%
1,785
FIVE icon
1315
Five Below
FIVE
$8.46B
$118K ﹤0.01%
1,015
FRPT icon
1316
Freshpet
FRPT
$2.7B
$118K ﹤0.01%
2,571
+1,014
+65% +$46.5K
IBRX icon
1317
ImmunityBio
IBRX
$2.27B
$118K ﹤0.01%
+26,714
New +$118K
SMTC icon
1318
Semtech
SMTC
$5.26B
$116K ﹤0.01%
2,162
-846
-28% -$45.4K
SPTN icon
1319
SpartanNash
SPTN
$908M
$116K ﹤0.01%
3,758
+3,159
+527% +$97.5K
TRUP icon
1320
Trupanion
TRUP
$1.9B
$116K ﹤0.01%
1,869
SFM icon
1321
Sprouts Farmers Market
SFM
$13.6B
$115K ﹤0.01%
4,309
+564
+15% +$15.1K
XENE icon
1322
Xenon Pharmaceuticals
XENE
$3.02B
$115K ﹤0.01%
3,581
-745
-17% -$23.9K
NGM
1323
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$115K ﹤0.01%
+7,407
New +$115K
ARQT icon
1324
Arcutis Biotherapeutics
ARQT
$2.06B
$114K ﹤0.01%
+4,774
New +$114K
INSM icon
1325
Insmed
INSM
$30.7B
$114K ﹤0.01%
4,918